Lyndon A. M. Cornelius

Author

Bristol-Myers Squibb (United States)ORCID

Also Known As

Cornelius, L.A.M., Cornelius, Lyndon, Cornelius, Lyndon A. M., L. A. M. CORNELIUS, Lyndon A Cornelius, Lyndon A. Cornelius, Lyndon A. M. Cornelius, Lyndon A.M Cornelius, Lyndon A.M. Cornelius, Lyndon Cornelius

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (India)Biocon (India)Wilmington University Johnson & Johnson (United States)

About

Lyndon A. M. Cornelius is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.9K
2	Natural Sciences	9	9	590
3	Biochemistry	7	7	505
4	Biomolecular Engineering	5	5	138
5	Engineering	3	3	116

Lyndon A. M. Cornelius

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays Louis J. Lombardo, Francis Y. Lee, Ping Chen, Journal of Medicinal Chemistry Drug TargetPreclinical AssaysPharmacotherapyCompound 13Pharmaceutical Chemistry	2004	1.3K
Discovery of <i>N</i>-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily Gretchen M. Schroeder, Yongmi An, Zhen‐Wei Cai, Journal of Medicinal Chemistry Orally Efficacious InhibitorDrug TargetPharmacotherapyPharmaceutical ChemistryTumor Biology	2009	276
Synthesis of Cyclobutane-Fused Tetracyclic Scaffolds via Visible-Light Photocatalysis for Building Molecular Complexity Martins S. Oderinde, Edna Mao, Antonio Ramı́rez, Journal of the American Chemical Society	2020	144
Facile Preparation of 2,6-Disubstituted Purines Using Solid-Phase Chemistry David A. Nugiel, Lyndon A. M. Cornelius, Jeffrey W. Corbett The Journal of Organic Chemistry Medicinal ChemistryPharmaceutical ScienceNatural SciencesMedicine2,6-Disubstituted Purines	1997	78
DBS Sampling Can be Used to Stabilize Prodrugs in Drug Discovery Rodent Studies without the Addition of Esterase Inhibitors Celia D’Arienzo, Qin Ji, Lorell Discenza, Bioanalysis	2010	78
Photocatalytic Dearomative Intermolecular [2 + 2] Cycloaddition of Heterocycles for Building Molecular Complexity Martins S. Oderinde, Antonio Ramı́rez, T. G. Murali Dhar, The Journal of Organic Chemistry Combinatorial ChemistryEngineeringSynthetic PhotochemistryOrganic ChemistryChemistry	2020	78
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors Zhen‐Wei Cai, Donna Wei, Gretchen M. Schroeder, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ScienceBiochemistryMedicineNatural SciencesRational Drug Design	2008	64
Discovery of <i>N</i>-Isoxazolyl Biphenylsulfonamides as Potent Dual Angiotensin II and Endothelin A Receptor Antagonists Natesan Murugesan, John E. Tellew, Zhengxiang Gu, Journal of Medicinal Chemistry	2002	53
Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors Donald W. Combs, Kimberly Reese, Lyndon A. M. Cornelius, Journal of Medicinal Chemistry	1995	53
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors Kyoung Soon Kim, Songfeng Lu, Lyndon A. M. Cornelius, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacotherapyDrug DevelopmentEg5 Inhibitors	2006	50

Page 1